Reporte zur Charge DM9N3

Symptomtext

Severe allergic reaction that led to a hospitalization; This case was reported by a consumer via call center representative and described the occurrence of allergic reaction in a 57-year-old male patient who received Flu Seasonal QIV Quebec (FluLaval Tetra 2017-2018 season) (batch number DM9N3, expiry date 30th April 2018) for prophylaxis. Co-suspect products included flu seasonal qiv quebec pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 6th October 2017, the patient received FluLaval Tetra 2017-2018 season and Flulaval Tetra Pre-Filled Syringe Device. On an unknown date, unknown after receiving FluLaval Tetra 2017-2018 season and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced allergic reaction (serious criteria hospitalization). On an unknown date, the outcome of the allergic reaction was unknown. It was unknown if the reporter considered the allergic reaction to be related to FluLaval Tetra 2017-2018 season and Flulaval Tetra Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: The case was reported by the patient himself. The patient suffered from the severe allergic reaction that led to hospitalization. The reporter did not consent to follow up.